These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma. Thrift AP Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368 [TBL] [Abstract][Full Text] [Related]
6. Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants. Takata Y; Kristal AR; Santella RM; King IB; Duggan DJ; Lampe JW; Rayman MP; Blount PL; Reid BJ; Vaughan TL; Peters U PLoS One; 2012; 7(6):e38612. PubMed ID: 22715394 [TBL] [Abstract][Full Text] [Related]
7. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963 [TBL] [Abstract][Full Text] [Related]
9. Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population. Ibiebele TI; Hughes MC; Nagle CM; Bain CJ; Whiteman DC; Webb PM; Int J Cancer; 2013 Jul; 133(1):214-24. PubMed ID: 23292980 [TBL] [Abstract][Full Text] [Related]
10. Predictors of dysplastic and neoplastic progression of Barrett’s esophagus. Alnasser S; Agnihotram R; Martel M; Mayrand S; Franco E; Ferri L Can J Surg; 2019 Apr; 62(2):93-99. PubMed ID: 30907564 [TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus and its progression to adenocarcinoma. Maley CC; Rustgi AK J Natl Compr Canc Netw; 2006 Apr; 4(4):367-74. PubMed ID: 16569389 [TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia. Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452 [TBL] [Abstract][Full Text] [Related]
13. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. Hardikar S; Onstad L; Blount PL; Odze RD; Reid BJ; Vaughan TL PLoS One; 2013; 8(1):e52192. PubMed ID: 23300966 [TBL] [Abstract][Full Text] [Related]
14. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. Galipeau PC; Li X; Blount PL; Maley CC; Sanchez CA; Odze RD; Ayub K; Rabinovitch PS; Vaughan TL; Reid BJ PLoS Med; 2007 Feb; 4(2):e67. PubMed ID: 17326708 [TBL] [Abstract][Full Text] [Related]
15. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study. Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896 [TBL] [Abstract][Full Text] [Related]
16. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis. Wang F; Lv ZS; Fu YK Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention in Barrett's oesophagus. Baruah A; Buttar NS Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):151-65. PubMed ID: 25743463 [TBL] [Abstract][Full Text] [Related]
19. Incidence of adenocarcinoma among patients with Barrett's esophagus. Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385 [TBL] [Abstract][Full Text] [Related]
20. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]